In the world of science, getting accurate and consistent results is key. Thanks to artificial intelligence and automation advancements, achieving this is now easier than ever. Take, for example, the APAS® PharmaQC product from Australian MedTech company LBT Innovations (ASX: LBT). Using AI technology, microbiologists can analyse multiple culture plates. By removing the variability often
Read More
Aussie cleantech company Parkway (ASX: PWN), which builds water treatment solutions, has acquired Tankweld Group, comprising the Tankweld Engineering Service and Tankweld Installations divisions. The $2.6 million acquisition of Tankweld Group has major benefits for Parkway. First, the Company now has greater project execution capabilities, which helps in technology commercialisation. Second, the acquisition improves Parkway’s
Read More
As artificial intelligence (AI) looms as the biggest disrupter to business over the next decade, Australian investors have been closely monitoring the ASX with brokers Evolution Capital confirming they will fully underwrite a $2.7m capital raise by AI company UNITH (ASX: UNT) The commitment to fully underwrite comes with UNITH and Evolution having worked together
Read More
Since last month, intellectual property services provider QANTM (ASX: QIP) has come into the spotlight following strong H1 FY24 results. So much so that it caught the eye of three companies wanting to acquire it. QANTM capitalises on the growth of the broader intellectual property rights industry. Australian businesses with IP rights account for around
Read More
In a bid to enhance travel options for passengers, Rex Airlines (ASX: REX) has confirmed a major partnership with Etihad Airways, one of the world’s leading airlines based in the United Arab Emirates. This collaboration between Rex and Etihad is set to give passengers in both Australia and abroad more flexibility with their travel in
Read More
Technological advancements, geopolitical tensions, and military modernisation programs are the factors driving market in the forecast period 2025-2029. According to TechSci Research report, “Defense Support and Auxiliary Equipment Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2029”, The Global Defense Support and Auxiliary Equipment Market stood at USD 153.85 Billion in 2023 and
Read More
Biotech company Mesoblast (ASX: MSB) has received positive feedback from the US Food and Drug Administration (FDA) for a new heart failure treatment called rexlemestrocel-L. This treatment aims to help people with severe heart failure, particularly those who have reached the end stages of the condition. Heart failure affects millions of people worldwide, with many
Read More
Semiconductor company Archer Materials (ASX: AXE) has achieved a major milestone in its Biochip technology development by significantly reducing the size of its gFET (graphene field-effect transistor) chip. This achievement resulted from redesigning the circuit layouts, leading to a substantial decrease in chip size that has the potential to increase its utility in medical diagnostics.
Read More
Canadian biotech company Tryp Therapeutics (CSE: TRYP) is set to list on the ASX through a backdoor merger with genetic medicines developer Exopharm (ASX: EX1) in a $14.3 million acquisition agreement. Following this agreement, Exopharm will change its name to Tryp and re-list on the ASX. On completion of the Transaction (Completion), Exopharm will be
Read More
The conversations surrounding artificial intelligence (AI) and its scope to transform the pharma industry have been underway for a while now. In fact, reports suggest that the global health-related AI market is set to be worth $284bn by 2030. Pharmaceutical development company Algorae (ASX: 1AI) is one of the companies at the forefront of this
Read More
